Several tumorigenic assays were conducted in ovarian cancer cell models using gain- and loss-of function of FOXM1 through enforced expression of FOXM1 or inhibition of endogenous FOXM1 by thiostrepton or U0126. This evidence concerns the gene FOXM1 and ovarian carcinoma.